Wyatt Technology Announces Executive Team Changes

Article

Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.

Wyatt Technology, a developer of instrumentation for absolute macromolecular and nanoparticle characterization, announced changes to its executive team on May 1, 2018.

Geofrey Wyatt was named chief executive office, and Clifford Wyatt was named president. Philip Wyatt, who founded the company almost 40 years ago, will become chairman of the board and take on a more passive role, the company reported in a press statement.

The company also announced that Michelle Chen was promoted to vice-president of analytical services and will join the executive team.

Source: Wyatt Technology

 

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Recent Videos
Related Content
Syringe aimed at the center of a target. Pharmacogenetics concept, symbolizing precise drug delivery based on genetic profiles. Low poly style | Image Credit: ©Елена Бутусова -stock.adobe.com

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

Cynthia A. Challener
July 4th 2025
Article

Advanced modeling provides greater understanding for more-informed decision making across all phases of drug development.

Column chromatography | Image credit: ©Alen – stock.adobe.com

Optimizing Downstream Processes for Biotherapeutic Development with Prepacked Chromatography Columns

Laura Kronbetter
July 3rd 2025
Article

As development of novel drugs accelerates, enhanced downstream production processes maintain product efficacy, safety, and quality.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Ecolab Introduces New Bioprocessing Purification Resin at BIO 2025

Susan Haigney
June 17th 2025
Article

The Purolite AP+50 affinity chromatography resin has a 50-micron bead size that offers dynamic binding capacity of the AP resin platform while providing durability for monoclonal antibody capture.

3D rendered blue laboratory test tubes with red positive results | Image Credit: © mguido - stock.adobe.com

Therapeutic and Analytical Advancements Are Evolving Drug Substance Testing

Patrick Lavery
June 5th 2025
Article

Quality, stability, sustainability, and the increased and thoughtful integration of artificial intelligence are foremost in the minds of those on the leading edge of testing trends.

Genetic engineering concept. Collage with glowing DNA molecule over female hand on blue background | Image Credit: © Prostock-studio

Mirai Bio and Thermo Fisher Partner to Advance Genetic Medicine Manufacturing

Christopher Cole
May 21st 2025
Article

Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development of genetic medicines.

Science, woman and man looking at test tube in laboratory, research in vaccine results and medical innovation. Healthcare, biotech lab analytics and medicine, scientist team in pharmaceutical study. | Image Credit: ©Talia Mdlungu/peopleimages.com – stock.adobe.com

The Use of Analytics in Biopharmaceuticals: An Introduction

Robert Dream
May 4th 2025
Article

This article provides an overview and introduction to the use of analytics in biopharmaceutical development and manufacturing.

© 2025 MJH Life Sciences

All rights reserved.